Reproductive outcome after medical management of complicated pelvic inflammatory disease

John R. Brumsted, J R Brumsted, Patrick M. Clifford, P M Clifford, S T Nakajima, Steven T. Nakajima, Mark Gibson, M Gibson
Fertility and sterility · 1988 · vol. 50(4) , pp. 667–669 · doi:10.1016/s0015-0282(16)60206-6 · PMID:3169291 · W2414930438
Observational OA: closed CC0 ⤵ 1 in-corpus citation
🔓 Open OA copy View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-12 ⓘ

This paper investigated the reproductive outcomes for women who experienced complicated pelvic inflammatory disease managed medically.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

A significant proportion of women with PID will have their disease complicated by a TOC. We conclude that it is appropriate in women with this stage of PID to treat initially with clindamycin and an aminoglycoside. In addition, since more than half of the women will suffer reproductive difficulties, efforts to improve early diagnosis and therapy should continue. Based on our data, an early infertility evaluation is indicated in women wishing to conceive after complicated PID.

My notes (saved in your browser only)

MeSH descriptors

Infertility, Female Pelvic Inflammatory Disease Aminoglycosides Aminoglycosides Clindamycin Clindamycin Female Humans Infertility, Female Pelvic Inflammatory Disease Pelvic Inflammatory Disease Pelvic Inflammatory Disease Retrospective Studies Salpingitis Salpingitis Salpingitis

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (2)

References (7)

Source provenance

openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-10-08T21:25:50.035457+00:00
unpaywall
last seen: 2026-09-17T06:32:46.214484+00:00
License: CC0 · commercial use OK